Review Article on Brugada Syndrome: Etiopathophysiological Basis and Medico Surgical and Nursing Modalities

Abstract

Brugada syndrome is an inherited condition that grades in abnormal electrical activity within the heart, growing the danger of abrupt cardiac death. Those affected may have incidents of passing out. The condition affects between 1 and 30 per 10,000 people. It is more common in males than females and in those of Asian descent. The beginning of indications is usually in adulthood. It is named after the Spanish cardiologists Pedro and Josep Brugada who labelled the condition in 1992. Their brother Ramon Brugada was the first to define one possible genetic cause in 1998. Irregular heart rhythm often happens when a person is at break and may be triggered by a fever. Patients with Brugada syndrome are liable to grow ventricular tachyarrhythmias that may central to syncope, cardiac arrest, or abrupt cardiac death. Infrahisian conduction delay and atrial fibrillation may also be manifestations of the syndrome. About 5% of survivors of cardiac arrest have no clinically recognized cardiac irregularity. About half of these belongings are supposed to be due to Brugada syndrome. At present, establishment of an unconscious implantable cardiac defibrillator (ICD) is the only conduct proven real in giving ventricular tachycardia and fibrillation and stopping rapid death in patients with Brugada syndrome.